Abstract:Objective: The paper studied the effect of Methamphetamine (MDMA) on myocardial gap junction protein to further reveal the molecular toxicological mechanism of Methamphetamine directly inducing cardiotoxicity,does it affect the expression, distribution, and phosphorylation status of connexin 43 in myocardial cells, inducing cardiac dysfunction. Methods: Select 1-day SPF grade neonatal rats, obtain purified ventricular myocytes, and undergo acute exposure for 1 hour to establish an in vitro model of MDMA acute exposure.An in vitro MDMA acute exposure model was constructed to observe the effects of acute exposure to different concentrations of MDMA on the expression and transcription level of CX43 protein in ventricular myocytes; the effect on the content and distribution of mouse ventricular myocyte Connexin 43; the influence on the phosphorylation status of Ser368 at the phosphorylation site of protein 43; and the effects on the intracellular calcium oscillation mode and the intracellular calcium ion concentration. Results: The content of total Connexin 43 in cardiomyocytes of the acute MDMA exposure group decreased significantly. Immunofluorescence detection of MDMA found that the content of Connexin 43 in the gap junction decreased with abnormal distribution. MDMA can lead to changes in the phosphorylation status of Connexin 43, which is manifested as an increase in the proportion of non-phosphorylation status, and can also increase the phosphorylation level of site Ser368. MDMA can change the calcium oscillation mode and rise of calcium ion concentration in cardiomyocytes. Conclusion: MDMA can destroy the calcium homeostasis in cardiomyocytes and affect the expression, distribution, and phosphorylation state of cardiomyocyte Connexin 43. This is also one of the potential mechanisms concerning the direct myocardial toxicity of MDMA. Practical application: MDMA is a kind of amphetamine derivative, a class of synthetic non-catecholamine sympathomimetic drugs. It can selectively act on the central nervous system above the brainstem to stimulate the neurosynaptic precursors to release serotonin (5-HT) and the monoamine neurotransmitters dopamine (DA) and norepinephrine (NE). After taking it, people may experience elevated mood, euphoria, sexual impulse, and involuntary head shaking caused by sympathetic nerve excitement.

MDMA decreases glutamic acid decarboxylase (GAD) 67-immunoreactive neurons in the hippocampus and increases seizure susceptibility: Role for glutamate

3,4—Methylenedioxymethamphetamine（mdma） Abuse Markedly Inhibits Acetylcholinesterase Activity and Induces Severe Oxidative Damage and Liperoxidative Damage

N-Acetyl and Glutamatergic Neurometabolites in Perisylvian Brain Regions of Methamphetamine Users

5-HT2C receptors in the nucleus accumbens constrain the rewarding effects of MDMA

3,4-Methylenedioxymethamphetamine (MDMA) impairs cognitive function during withdrawal via activation of the arachidonic acid cascade in the hippocampus

NMDA Receptor Hypofunction Induces Dysfunctions of Energy Metabolism and Semaphorin Signaling in Rats: a Synaptic Proteome Study.

NMDA receptor adjusted co-administration of ecstasy and cannabinoid receptor-1 agonist in the amygdala via stimulation of BDNF/Trk-B/CREB pathway in adult male rats

Increased Anxiety 3 Months after Brief Exposure to MDMA (‘Ecstasy’) in Rats: Association with Altered 5-HT Transporter and Receptor Density

Vesicular monoamine transporter 2 and the acute and long-term response to 3,4-(±)-methylenedioxymethamphetamine

Methylenedioxymethamphetamine ('Ecstasy')-induced immunosuppression: a cause for concern?

The Effect of Methamphetamine on Ventricular Myocytes of Neonatal Rats

MDMA induces cardiac contractile dysfunction through autophagy upregulation and lysosome destabilization in rats

Metabolites Alterations in the Medial Prefrontal Cortex of Methamphetamine Users in Abstinence: A 1H MRS Study

Differential long-term effects of MDMA on the serotoninergic system and hippocampal cell proliferation in 5-HTT knock-out vs. wild-type mice

Postnatal exposure to MK801 induces selective changes in GAD67 or parvalbumin

Serotonin mediates rapid changes of striatal glucose and lactate metabolism after systemic 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") administration in awake rats

Neuropharmacological Evidence Implicating Drug-Induced Glutamate Receptor Dysfunction in Affective and Cognitive Sequelae of Subchronic Methamphetamine Self-Administration in Mice

Glial–Neuronal Interactions are Impaired in the Schizophrenia Model of Repeated MK801 Exposure

3,4-Methylenedioxymethamphetamine alters left ventricular function and activates nuclear factor-Kappa B (NF-κB) in a time and dose dependent manner

Pharmacological Mechanisms Involved in Sensory Gating Disruption Induced by (±)-3,4-Methylene- Dioxymethamphetamine (MDMA): Relevance to Schizophrenia

Modulation of Gut Microbiome in Ecstasy/MDMA-Induced Behavioral and Biochemical Impairment in Rats and Potential of Post-Treatment with Anacyclus pyrethrum L. Aqueous Extract to Mitigate Adverse Effects